Newsletter - October 2024
Dear Readers,
We are pleased to present you our HiPP science newsletter for healthcare professionals!
Current studies summarised & reviewed:
Read interesting articles on the topic of paediatrics and nutritional medicine. We hope you will find them interesting!
Best wishes
Christina Reisenzein
Editor of HiPP for Health Care Professionals
News from HiPP
For a strong immune system during the cold season
Children suffer from acute respiratory infections with particular frequency. The GOLF III trial indicates that HiPP ORGANIC COMBIOTIK® can reduce lower respiratory tract infections in non-breastfed infants during the upcoming cold season.
HiPP has set a new standard in sustainable corporate management: first company in Austria, Hungary and Croatia that is certified with 'We Impact'
This certification is an important step for HiPP and demonstrates our commitment to environmental management.
Eliminate the horror of food allergies?
A completely different approach, involving treatment with the monoclonal anti-IgE antibody omalizumab in children and adolescents with severe allergies to dietary proteins, has now been tested.
Abdominal pain and irritable bowel syndrome – how should they be treated?
Recurrent abdominal pain is one of the most common reasons for children to see a doctor. Linaclotide has now been tested in a phase 2 study on children with irritable bowel syndrome.
A fun way to combat pain
Venipunctures are one of the most stressful situations in clinics and practices. This study gives two further suggestions and shows that the more attractive the distractions are, the better they work.
C-section birth has negative effects on breastfeeding success
Researchers in the UK have investigated the extent to which the breastfeeding rate and breastfeeding success are influenced by the delivery method.
HiPP Science Newsletter
